MAYO 2008
{phocadownload view=file|id=37|target=_blank|text=Actualizacion sobre el tratamiento de la nefritis lupica}
{phocadownload view=file|id=36|target=_blank|text=Bmj 2005 Recurrent urinary tract infection in women}
• Brunzell JD, Davidson M, Furberg CD, et al. Lipoprotein management in patients with cardiometabolic risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
Diabet Care (Apr) 31:811-822, 2008.
• Nissen SE, Nicholls SJ, Wolski K, et al for the STRADIVARIUS Investigators. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: The STRADIVARIUS Randomized Controlled Trial. J Am Med Assoc (Apr) 299:1547-1560, 2008
• Textor SC. Atherosclerotic renal artery stenosis: Overtreated but underrated? J Am Soc Nephrol (Apr) 19:656-659, 2008 .
• The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med(Apr) 358:1547-1559, 2008.
• Kane GC, Stanson AW, Kalnicka D, et al. Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. Nephrol Dial Transplant(Apr) 23:1233-1230, 2008.
• De Zeeuw D. Targeting proteinuria as a valid surrogate for individualized kidney protective therapy. Am J Kidney Dis(May) 51:713-716, 2008.
• James MT, Conley J, Tonelli M, et al. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med(Apr) 148:596-605, 2008.
• Bleyer AJ. Prevention of sudden cardiac death in dialysis patients: a nephrologist's perspective. Dial Transplant(Apr) 37:124-129, 2008.
• Ahlmen J, Gydell KH, Hadimeri H, et al. A new safety device for hemodialysis. Hemodial Int(Apr) 12:264-267, 2008.
• Li H, Wang SX. Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. Perit Dial Int (Apr) 28:149-154, 2008.
• Verbeke F, Van Biesen W, Pletinck A, et al. Acute central hemodynamic effects of a volume exchange in peritoneal dialysis. Perit Dial Int(Apr) 28:142-148, 2008.
• Knopp EA, Copwer SE. Nephrogenic systemic fibrosis: early recognition and treatment. Semin Dial (Apr) 21:123-128, 2008.
• Brunet P, Simon N, Opris A, et al. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session. Am J Kidney Dis(May) 51:789-795, 2008.
• Brophy DF. Efficacy and safety of fondaparinux and enoxaparin for acute coronary syndromes in CKD. Am J Kidney Dis(May) 51:719-723, 2008
• Gashti CN, Salcedo S, Robinson V, et al. Accelerated venovenous hemofiltration: early technical and clinical experience. Am J Kidney Dis (May) 51:804-810, 2008
• Wang W, Tonelli M, Hemmelgarg B, et al. The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trial. Am J Kidney Dis(May) 51:796-803, 2008.
• Kishimoto TK, Viswanathan K, Ganguly T, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med(Jun) 358:on-line, 2008
• Schwartz MM, Korbet SM, Lewis EJ for the Collaborative Study Group. The prognosis and pathogenesis of severe lupus glomerulonephritis. Nephrol Dial Transplant(Apr) 23:1298-1306, 2008
• Szeto CC, Chow KM, Kwan BCH, et al. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial. Am J Kidney Dis(May) 51:724-732, 2008
• Wu HY, Hung KY, Huang JW, et al. Initial glucose load predicts technique survival in patients on chronic peritoneal dialysis.
Am J Nephrol (Jun) 28:765-771, 2008
• Fervenza FC, Sethi S, Specks U. Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol(May) 3:905-919, 2008
